The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The impact of glucagon-like peptide 1 agonists on anthracycline or human epidermal growth factor receptor 2 inhibitor-associated cardiotoxicity in patients with breast cancer and diabetes mellitus.
 
Cho Han Chiang
No Relationships to Disclose
 
Yu-Cheng Chang
No Relationships to Disclose
 
Zhiting Tang
No Relationships to Disclose
 
Xin Ya See
No Relationships to Disclose
 
Kuan-Yu Chi
No Relationships to Disclose
 
Yu Chang
No Relationships to Disclose
 
Cho Hung Chiang
No Relationships to Disclose
 
Azin Ghamari
No Relationships to Disclose
 
Lauren Mary Curtis
No Relationships to Disclose
 
Tomas G. Neilan
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; C4 Therapeutics; CRC Oncology; Intrinsic Imaging; Parexel; Roche/Genentech; Sanofi
Research Funding - AstraZeneca; Bristol Myers Squibb Foundation